Tumor marker gene test with CA19-9: Clinical Trials

1 recruiting. 1 Phase 3.

By phase and status

Phase	Trials	Status
Phase 3	1	Recruiting 1

Follow Tumor marker gene test with CA19-9: new trials by email Literature Review of Tumor marker gene test with CA19-9 trials Research Report on Tumor marker gene test with CA19-9

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
The Cancer of the Pancreas Screening-5 CAPS5)Study Secretin, MRI, Tumor marker gene test with CA19-9 - Pancreas Cancer, Peutz-Jeghers Syndrome (PJS)	Phase 3	Recruiting	Johns Hopkins University	9000	2014-01-06	2026-10-22

Conditions studied

Breast Neoplasms (1)  ·  Colorectal Neoplasms, Hereditary Nonpolyposis (1)  ·  Dysplastic Nevus Syndrome (1)  ·  Hereditary Sensory and Autonomic Neuropathies (1)  ·  Hereditary pancreatitis (1)  ·  Pancreatic Neoplasms (1)  ·  Peutz-Jeghers Syndrome (1)

Sponsors

Johns Hopkins University (1)

Countries

United States (1)

Top investigators

Michael Goggins, MD (1)

Results publications

PMID 31197699, PMID 31676359, PMID 33161160, PMID 34149034

NIH funding

R01CA176828 (1), U01CA210170 (1)